{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:31:41Z","timestamp":1790015501632,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010814","name":"Anhui Provincial Department of Education","doi-asserted-by":"publisher","award":["2022AH051178"],"award-info":[{"award-number":["2022AH051178"]}],"id":[{"id":"10.13039\/501100010814","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Anhui Natural Science Foundation of China","award":["2008085MH296"],"award-info":[{"award-number":["2008085MH296"]}]},{"name":"Anhui Medical University Natural Science Foundation","award":["2020xkj186"],"award-info":[{"award-number":["2020xkj186"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s11010-023-04906-w","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T13:03:15Z","timestamp":1704459795000},"page":"3077-3089","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1"],"prefix":"10.1007","volume":"479","author":[{"given":"Jing","family":"Bao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixiang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"key":"4906_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1001\/jama.2022.0003","volume":"327","author":"AJ Cowan","year":"2022","unstructured":"Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, Tuazon S, Gopal AK, Libby EN (2022) Diagnosis and management of multiple myeloma: a review. JAMA 327:464\u2013477. https:\/\/doi.org\/10.1001\/jama.2022.0003","journal-title":"JAMA"},{"key":"4906_CR2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13045-019-0807-5","volume":"12","author":"J Liu","year":"2019","unstructured":"Liu J, Liu W, Mi L, Zeng X, Cai C, Ma J, Wang L (2019) Incidence and mortality of multiple myeloma in China, 2006\u20132016: an analysis of the Global Burden of Disease Study 2016. J Hematol Oncol 12:136. https:\/\/doi.org\/10.1186\/s13045-019-0807-5","journal-title":"J Hematol Oncol"},{"key":"4906_CR3","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13045-022-01301-8","volume":"15","author":"WH Zhao","year":"2022","unstructured":"Zhao WH, Wang BY, Chen LJ, Fu WJ, Xu J, Liu J, Jin SW, Chen YX, Cao XM, Yang Y, Zhang YL, Wang FX, Zhang PY, Lei B, Gu LF, Wang JL, Zhang H, Bai J, Xu Y, Zhu H, Du J, Jiang H, Fan XH, Li JY, Hou J, Chen Z, Zhang WG, Mi JQ, Chen SJ, He AL (2022) Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2). J Hematol Oncol 15:86. https:\/\/doi.org\/10.1186\/s13045-022-01301-8","journal-title":"J Hematol Oncol"},{"key":"4906_CR4","doi-asserted-by":"publisher","first-page":"6251","DOI":"10.1093\/nar\/gkaa347","volume":"48","author":"H Zhang","year":"2020","unstructured":"Zhang H, Shi X, Huang T, Zhao X, Chen W, Gu N, Zhang R (2020) Dynamic landscape and evolution of m6A methylation in human. Nucleic Acids Res 48:6251\u20136264. https:\/\/doi.org\/10.1093\/nar\/gkaa347","journal-title":"Nucleic Acids Res"},{"key":"4906_CR5","doi-asserted-by":"publisher","first-page":"D134","DOI":"10.1093\/nar\/gkaa692","volume":"49","author":"Y Tang","year":"2021","unstructured":"Tang Y, Chen K, Song B, Ma J, Wu X, Xu Q, Wei Z, Su J, Liu G, Rong R, Lu Z, de Magalh\u00e3es JP, Rigden DJ, Meng J (2021) m6A-Atlas: a comprehensive knowledgebase for unraveling the N6-methyladenosine (m6A) epitranscriptome. Nucleic Acids Res 49:D134-d143. https:\/\/doi.org\/10.1093\/nar\/gkaa692","journal-title":"Nucleic Acids Res"},{"key":"4906_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-021-01066-6","volume":"14","author":"F Jiang","year":"2021","unstructured":"Jiang F, Tang X, Tang C, Hua Z, Ke M, Wang C, Zhao J, Gao S, Jurczyszyn A, Janz S, Beksac M, Zhan F, Gu C, Yang Y (2021) HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA. J Hematol Oncol 14:54. https:\/\/doi.org\/10.1186\/s13045-021-01066-6","journal-title":"J Hematol Oncol"},{"key":"4906_CR7","doi-asserted-by":"publisher","first-page":"5393","DOI":"10.1038\/s41388-021-01939-7","volume":"40","author":"S Song","year":"2021","unstructured":"Song S, Fan G, Li Q, Su Q, Zhang X, Xue X, Wang Z, Qian C, Jin Z, Li B (2021) IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma. Oncogene 40:5393\u20135402. https:\/\/doi.org\/10.1038\/s41388-021-01939-7","journal-title":"Oncogene"},{"key":"4906_CR8","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.ymthe.2021.12.012","volume":"30","author":"A Xu","year":"2022","unstructured":"Xu A, Zhang J, Zuo L, Yan H, Chen L, Zhao F, Fan F, Xu J, Zhang B, Zhang Y, Yin X, Cheng Q, Gao S, Deng J, Mei H, Huang Z, Sun C, Hu Y (2022) FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m(6)A-YTHDF2-dependent manner. Mol Ther 30:1104\u20131118. https:\/\/doi.org\/10.1016\/j.ymthe.2021.12.012","journal-title":"Mol Ther"},{"key":"4906_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s10565-021-09690-1","author":"F Che","year":"2022","unstructured":"Che F, Ye X, Wang Y, Wang X, Ma S, Tan Y, Mao Y, Luo Z (2022) METTL3 facilitates multiple myeloma tumorigenesis by enhancing YY1 stability and pri-microRNA-27 maturation in m(6)A-dependent manner. Cell Biol Toxicol. https:\/\/doi.org\/10.1007\/s10565-021-09690-1","journal-title":"Cell Biol Toxicol"},{"key":"4906_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nature20577","volume":"540","author":"IU Haussmann","year":"2016","unstructured":"Haussmann IU, Bodi Z, Sanchez-Moran E, Mongan NP, Archer N, Fray RG, Soller M (2016) m(6)A potentiates Sxl alternative pre-mRNA splicing for robust Drosophila sex determination. Nature 540:301\u2013304. https:\/\/doi.org\/10.1038\/nature20577","journal-title":"Nature"},{"key":"4906_CR11","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1101\/gad.269415.115","volume":"29","author":"S Ke","year":"2015","unstructured":"Ke S, Alemu EA, Mertens C, Gantman EC, Fak JJ, Mele A, Haripal B, Zucker-Scharff I, Moore MJ, Park CY, V\u00e5gb\u00f8 CB, Kus\u015bnierczyk A, Klungland A, Darnell JE Jr, Darnell RB (2015) A majority of m6A residues are in the last exons, allowing the potential for 3\u2032 UTR regulation. Genes Dev 29:2037\u20132053. https:\/\/doi.org\/10.1101\/gad.269415.115","journal-title":"Genes Dev"},{"key":"4906_CR12","doi-asserted-by":"publisher","first-page":"16011","DOI":"10.1038\/nmicrobiol.2016.11","volume":"1","author":"G Lichinchi","year":"2016","unstructured":"Lichinchi G, Gao S, Saletore Y, Gonzalez GM (2016) Dynamics of the human and viral m(6)A RNA methylomes during HIV-1 infection of T cells. Nat Microbiol 1:16011. https:\/\/doi.org\/10.1038\/nmicrobiol.2016.11","journal-title":"Nat Microbiol"},{"key":"4906_CR13","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","volume":"161","author":"X Wang","year":"2015","unstructured":"Wang X, Zhao BS, Roundtree IA, Lu Z, Han D, Ma H, Weng X, Chen K, Shi H, He C (2015) N(6)-methyladenosine modulates messenger RNA translation efficiency. Cell 161:1388\u20131399. https:\/\/doi.org\/10.1016\/j.cell.2015.05.014","journal-title":"Cell"},{"key":"4906_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/nature12730","volume":"505","author":"X Wang","year":"2014","unstructured":"Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, Fu Y, Parisien M, Dai Q, Jia G, Ren B, Pan T, He C (2014) N6-methyladenosine-dependent regulation of messenger RNA stability. Nature 505:117\u2013120. https:\/\/doi.org\/10.1038\/nature12730","journal-title":"Nature"},{"key":"4906_CR15","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature14281","volume":"519","author":"CR Alarc\u00f3n","year":"2015","unstructured":"Alarc\u00f3n CR, Lee H, Goodarzi H, Halberg N, Tavazoie SF (2015) N6-methyladenosine marks primary microRNAs for processing. Nature 519:482\u2013485. https:\/\/doi.org\/10.1038\/nature14281","journal-title":"Nature"},{"key":"4906_CR16","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.cell.2015.08.011","volume":"162","author":"CR Alarc\u00f3n","year":"2015","unstructured":"Alarc\u00f3n CR, Goodarzi H, Lee H, Liu X, Tavazoie S, Tavazoie SF (2015) HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events. Cell 162:1299\u20131308. https:\/\/doi.org\/10.1016\/j.cell.2015.08.011","journal-title":"Cell"},{"key":"4906_CR17","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1016\/j.celrep.2017.08.027","volume":"20","author":"C Zhou","year":"2017","unstructured":"Zhou C, Molinie B, Daneshvar K, Pondick JV, Wang J, Van Wittenberghe N, Xing Y, Giallourakis CC, Mullen AC (2017) Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs. Cell Rep 20:2262\u20132276. https:\/\/doi.org\/10.1016\/j.celrep.2017.08.027","journal-title":"Cell Rep"},{"key":"4906_CR18","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1093\/nar\/gky130","volume":"46","author":"D Yang","year":"2018","unstructured":"Yang D, Qiao J, Wang G, Lan Y, Li G, Guo X, Xi J, Ye D, Zhu S, Chen W, Jia W, Leng Y, Wan X, Kang J (2018) N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential. Nucleic Acids Res 46:3906\u20133920. https:\/\/doi.org\/10.1093\/nar\/gky130","journal-title":"Nucleic Acids Res"},{"key":"4906_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13045-018-0555-y","volume":"11","author":"MQ Cao","year":"2018","unstructured":"Cao MQ, You AB, Zhu XD, Zhang W, Zhang YY, Zhang SZ, Zhang KW, Cai H, Shi WK, Li XL, Li KS, Gao DM, Ma DN, Ye BG, Wang CH, Qin CD, Sun HC, Zhang T, Tang ZY (2018) miR-182-5p promotes hepatocellular carcinoma progression by repressing FOXO3a. J Hematol Oncol 11:12. https:\/\/doi.org\/10.1186\/s13045-018-0555-y","journal-title":"J Hematol Oncol"},{"key":"4906_CR20","doi-asserted-by":"publisher","first-page":"7074343","DOI":"10.1155\/2021\/7074343","volume":"2021","author":"X Wu","year":"2021","unstructured":"Wu X, Wang W (2021) miR-182\u20135p serves as an oncogene in lung adenocarcinoma through binding to STARD13. Comput Math Meth Med 2021:7074343. https:\/\/doi.org\/10.1155\/2021\/7074343","journal-title":"Comput Math Meth Med"},{"key":"4906_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/biom12020187","volume":"12","author":"MF Souza","year":"2022","unstructured":"Souza MF, C\u00f3lus IMS (2022) MiR-182\u20135p modulates prostate cancer aggressive phenotypes by targeting EMT associated pathways. Biomolecules. 12:187. https:\/\/doi.org\/10.3390\/biom12020187","journal-title":"Biomolecules."},{"key":"4906_CR22","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41419-021-03992-2","volume":"12","author":"K Du","year":"2021","unstructured":"Du K, Zhang Z, Zeng Z, Tang J, Lee T, Sun T (2021) Distinct roles of Fto and Mettl3 in controlling development of the cerebral cortex through transcriptional and translational regulations. Cell Death Dis 12:700. https:\/\/doi.org\/10.1038\/s41419-021-03992-2","journal-title":"Cell Death Dis"},{"key":"4906_CR23","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/and.14422","volume":"54","author":"D Wang","year":"2022","unstructured":"Wang D, Wang X, Huang B, Zhao Y, Tu W, Jin X, Shao Y, Zhu Y, Lu G (2022) METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner. Andrologia 54:1581\u20131591. https:\/\/doi.org\/10.1111\/and.14422","journal-title":"Andrologia"},{"key":"4906_CR24","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.bbrc.2022.08.036","volume":"626","author":"X Zhang","year":"2022","unstructured":"Zhang X, Tian L, Li Z, Liu R, Yu J, Liu B (2022) CAMK2N1 has a cancer-suppressive function in colorectal carcinoma via effects on the Wnt\/\u03b2-catenin pathway. Biochem Biophys Res Commun 626:220\u2013228. https:\/\/doi.org\/10.1016\/j.bbrc.2022.08.036","journal-title":"Biochem Biophys Res Commun"},{"key":"4906_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s13577-019-00276-y","volume":"32","author":"K Xu","year":"2019","unstructured":"Xu K, Hu X, Sun L, Liang Q, Ouyang G, Zhang Y, Mu Q, Yan X (2019) MicroRNA-532 exerts oncogenic functions in t(4;14) multiple myeloma by targeting CAMK2N1. Hum Cell 32:529\u2013539. https:\/\/doi.org\/10.1007\/s13577-019-00276-y","journal-title":"Hum Cell"},{"key":"4906_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/iub.2678","volume":"75","author":"J Wang","year":"2023","unstructured":"Wang J, Zuo Y, Lv C, Zhou M, Wan Y (2023) N6-methyladenosine regulators are potential prognostic biomarkers for multiple myeloma. IUBMB Life 75:137\u2013148. https:\/\/doi.org\/10.1002\/iub.2678","journal-title":"IUBMB Life"},{"key":"4906_CR27","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","volume":"13","author":"C Zeng","year":"2020","unstructured":"Zeng C, Huang W, Li Y, Weng H (2020) Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol 13:117. https:\/\/doi.org\/10.1186\/s13045-020-00951-w","journal-title":"J Hematol Oncol"},{"key":"4906_CR28","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1007\/s00277-023-05283-6","volume":"102","author":"X Huang","year":"2023","unstructured":"Huang X, Yang Z, Li Y, Long X (2023) m6A methyltransferase METTL3 facilitates multiple myeloma cell growth through the m6A modification of BZW2. Ann Hematol 102:1801\u20131810. https:\/\/doi.org\/10.1007\/s00277-023-05283-6","journal-title":"Ann Hematol"},{"key":"4906_CR29","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12943-019-1036-9","volume":"18","author":"J Han","year":"2019","unstructured":"Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q, Wei JF, Yang H (2019) METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221\/222 maturation in m6A-dependent manner. Mol Cancer 18:110. https:\/\/doi.org\/10.1186\/s12943-019-1036-9","journal-title":"Mol Cancer"},{"key":"4906_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1186\/s13046-019-1408-4","volume":"38","author":"W Peng","year":"2019","unstructured":"Peng W, Li J, Chen R, Gu Q, Yang P, Qian W, Ji D, Wang Q, Zhang Z, Tang J, Sun Y (2019) Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246\/SPRED2\/MAPK signaling pathway. J Exp Clin Cancer Res 38:393. https:\/\/doi.org\/10.1186\/s13046-019-1408-4","journal-title":"J Exp Clin Cancer Res"},{"key":"4906_CR31","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41417-020-00222-3","volume":"28","author":"X Bi","year":"2021","unstructured":"Bi X, Lv X, Liu D, Guo H, Yao G, Wang L, Liang X, Yang Y (2021) METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K\/Akt\/mTOR pathway. Cancer Gene Ther 28:335\u2013349. https:\/\/doi.org\/10.1038\/s41417-020-00222-3","journal-title":"Cancer Gene Ther"},{"key":"4906_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12943-022-01598-6","volume":"21","author":"B Yao","year":"2022","unstructured":"Yao B, Zhu S, Wei X, Chen MK, Feng Y, Li Z, Xu X, Zhang Y, Wang Y, Zhou J, Tang N, Ji C, Jiang P, Zhao SC, Qin C, Feng N (2022) The circSPON2\/miR-331-3p axis regulates PRMT5, an epigenetic regulator of CAMK2N1 transcription and prostate cancer progression. Mol Cancer 21:119. https:\/\/doi.org\/10.1186\/s12943-022-01598-6","journal-title":"Mol Cancer"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04906-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-023-04906-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04906-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T10:10:35Z","timestamp":1728900635000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-023-04906-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["4906"],"URL":"https:\/\/doi.org\/10.1007\/s11010-023-04906-w","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"assertion":[{"value":"18 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For patients: This project was approved by the Research Ethics Committee of Anhui Medical University (No. 20200040). All participants in this project signed the informed consent form.For animals: The animal experiments were carried out with the approval of the ethics committee of Anhui Medical University (No. 20190657).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}